Cambridge Phenotyping attracts 610K EUR investment

May 5, 2022
Coinvest, the acceleration fund 70V and business angels invest in Cambridge Phenotyping, a company founded by neuroscientists Julija Krupic and Marius Bauza.
Smart-Kage v2

In their recent announcement “Coinvest Capital” said:

“Together with business angels and the acceleration fund 70V, we invested in Cambridge Phenotyping, a company created by neuroscientists Julija Krupic and Marius Bauza.

They created artificial intelligence technology “Smart Kage” that helps to monitor and analyze rodent behavior in medical laboratories. It is an incredibly innovative research solution, which allows us to analyze the behavior of the animal 24 hours a day, 7 days a week.

We wish Cambridge Phenotyping the best in introducing the product to the market.”

transforming pre-clinical and basic science research on cognition and behaviour

Related Posts

Cell Reports Methods 2026 publication

Cell Reports Methods 2026 publication

Our fully automated novel object recognition (NOR) study using smart-Kages has been published in the January 2026 issue of Cell Reports Methods

AI-Powered Tech Enables Continuous Lab Animal Monitoring

AI-Powered Tech Enables Continuous Lab Animal Monitoring

As necessity is the mother of invention, Krupic teamed up with other scientists to develop smart-Kage, a fully automated home-cage monitoring system for mice. The system includes behavioral and cognitive tests, such as a T-maze and novel object recognition, to assess hippocampus function.

Sainsbury Wellcome Centre invites to meet Cambridge Phenotyping

Sainsbury Wellcome Centre invites to meet Cambridge Phenotyping

Meet Cambridge Phenotyping, co-founded by SWC Senior Research Fellow Marius Bauza and former SWC Postdoctoral Fellow Julija Krupic. They’re developing fully automated systems to monitor cognitive and behavioural phenotypes in preclinical and foundational research. The...

Uncovering the earliest signs of Alzheimer’s disease

Uncovering the earliest signs of Alzheimer’s disease

The entorhinal cortex and hippocampus, regions in the brain’s medial temporal lobe, are the first to exhibit neurodegeneration in Alzheimer’s. Work pioneered by Nobel Laureate Prof John O’Keefe (UK DRI Associate Member at UCL) has identified that neurons in these...